EAACI Guidelines
To add the references below to your reference management program: 1. Download the file; 2. Open your reference management program or EndNote; 3. Select File and import |
35 Articles |
-
EAACI Guidelines on Environmental Science for Allergy and Asthma—Evidence‐Based Recommendations for Prevention and Public Health Action to Mitigate the Impact of Pollen Exposure on Respiratory Allergy
L.Cecchi, I.Annesi‐Maesano, B.Biagioni, et al.Allergy. First published:26 June 2026
-
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines—2024–2025 Revision: Part II—Guidelines on Oral and Ocular Treatments
R. J.Vieira, B.Sousa-Pinto, J.Bousquet, et al.Allergy. First published: 24 March 2026
-
The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria
T. Zuberbier, Z. Abdul Hameed Ansari, A. H. Abdul Latiff et al.Allergy. First published:06 February 2026
-
EAACI Guidelines on the Importance of Green Space in Urban Environments for Allergy and Asthma Prevention
T. Haahtela, L. O'Mahony, C. Traidl-Hoffmann, et al.Allergy. First published: 13 December 2025
-
Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines—2024–2025 Revision: Part I—Guidelines on Intranasal Treatments
B. Sousa-Pinto, J. Bousquet, R. J. Vieira, et al. Allergy. First published:01 December 2025
-
International Evidence-Based Guidelines for Traditional Chinese Medicine Management of Allergic Rhinitis
Q.-W. Fu, P. Liu, Y. Ruan, et al. Allergy. First published: 13 September 2025
-
EAACI Guidelines on Environmental Science for Allergy and Asthma—Recommendations on the Impact of Indoor Air Pollutants on the Risk of New-Onset Asthma and on Asthma-Related Outcomes
Agache, I., Annesi-Maesano, I., Cecchi, L., et al. Allergy. First published: 28 February 2025
-
EAACI guidelines on the management of IgE-mediated food allergy
Santos AF, Riggioni C, Agache I, et al. Allergy. First published: 30 October 2024
-
The impact of exposure to tobacco smoke and e-cigarettes on asthma-related outcomes: Systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthma
Agache I, Ricci-Cabello I, Canelo-Aybar C, et al. Allergy. First published: 23 May 2024
-
EAACI guidelines on environmental science for allergy and asthma: The impact of short-term exposure to outdoor air pollutants on asthma-related outcomes and recommendations for mitigation measures
Agache I, Annesi-Maesano I, Cecchi L, et al. Allergy. First published: 02 April 2024
-
EAACI guidelines on the diagnosis of IgE-mediated food allergy
Santos AF, Riggioni C, Agache I, et al. Allergy. First published: 10 October 2023
-
EAACI guidelines on environmental science in allergic diseases and asthma – Leveraging artificial intelligence and machine learning to develop a causality model in exposomics
Shamji, MH, Ollert, M, Adcock, IM, et al. Allergy. First published: 05 February 2023
-
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis and management of urticaria
Zuberbier, T., Abdul Latiff, A., Abuzakouk, M., et al. Allergy. First published: 18 September 2021
-
EAACI biologicals guidelines – Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12-17 years old
Agache, I., Akdis, C., Akdis, M., et al. Allergy. First published: 29 July 2021
-
The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update
Maurer, M, Magerl, M, Betschel, S, et al. Allergy. 2022; 77: 1961– 1990
-
World Health Organization global air quality guideline recommendations: Executive summary
Goshua, A, Akdis, C, Nadeau, KC. Allergy. 2022; 77: 1955– 1960
-
EAACI guidelines: Anaphylaxis (2021 update)
Muraro, A, Worm, M, Alviani, C, et al. Allergy. 2022; 77: 357– 377
-
Dissemination of EAACI food allergy guidelines using a flexible, practical, whole school allergy awareness toolkit
Higgs, J., Styles, K., Bowyer, S., et al. Allergy. 2021; 76: 3479-3488
-
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines
Agache, I., Song, Y., Alonso-Coello, P., et al. Allergy. 2021; 76: 2337-2353
-
EAACI biologicals guidelines—dupilumab for children and adults with moderate-to-severe atopic dermatitis
Agache, I., Akdis, C.A., Akdis, M., et al. Allergy. 2021; 76: 988-1009
-
Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI biologicals guidelines
Agache, I, Rocha, C, Pereira, A, et al. Allergy. 2021; 76: 59– 70
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI guidelines - recommendations on the use of biologicals in severe asthma
Agache, I, Song, Y, Posso, M, et al. Allergy. 2021; 76: 45– 58
-
EAACI biologicals guidelines—recommendations for severe asthma
Agache, I, Akdis, CA, Akdis, M, et al. Allergy. 2021; 76: 14– 44
-
EAACI guideline on the effective transition of adolescents and young adults with allergy and asthma
Roberts, G, Vazquez-Ortiz, M, Knibb, R, et al. Allergy. 2020; 75: 2734– 2752
-
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma
Agache, I, Song, Y, Rocha, C, et al. Allergy. 2020; 75: 1058– 1068
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Agache, I, Rocha, C, Beltran, J, et al. Allergy. 2020; 75: 1043– 1057
-
Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines
Agache, I, Beltran, J, Akdis, C, et al. Allergy. 2020; 75: 1023– 1042
-
EAACI guidelines on allergen immunotherapy: House dust mite-driven allergic asthma
Agache, I, Lau, S, Akdis, CA, et al. Allergy. 2019; 74: 855– 873
-
The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update
Maurer, M, Magerl, M, Ansotegui, I, et al. et al. Allergy. 2018; 73: 1575– 1596.
-
EAACI Guidelines on allergen immunotherapy: Allergic rhinoconjunctivitis
Roberts, G, Pfaar, O, Akdis, CA, et al. Allergy. 2018; 73: 765– 798
-
EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy
Pajno, GB, Fernandez-Rivas, M, Arasi, S, et al. Allergy. 2018; 73: 799– 815
-
EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy
Sturm, GJ, Varga, E-M, Roberts, G, et al. Allergy. 2018; 73: 744– 764
-
EAACI guidelines on allergen immunotherapy: Executive statement
Muraro, A., Roberts, G., Halken, S., et al. Allergy. 2018; 73: 739-743
-
EAACI guidelines on allergen immunotherapy-Out with the old and in with the new
Agache, I. Allergy. 2018; 73: 737-738